About MITRO
Exhibition | Mitro will soon participate in the SNMMI 2024 Annual Meeting
2024-04-30 02:38
2024 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in the United States.
The meeting will be held from June 8-11, 2024, in Toronto, Canada. The SNMMI annual meeting is recognized as the premier educational, scientific, research, and networking event in the field of nuclear medicine and molecular imaging, attracting thousands of professionals from around the world each year.
The Mitro booth is located at No. 151, welcoming physicians, technicians, scientists, entrepreneurs, and others to exchange and discuss the latest research achievements in the field of nuclear medicine and molecular imaging.
About Mitro
MITRO Biotech Co., Ltd. was established in 2012, focusing on providing professional and efficient CRO & CDMO services for radiolabeled molecular imaging in the global pharmaceutical and biopharmaceutical industry. Mitro utilizes radiolabeling and molecular imaging technologies to offer outsourced technical services such as drug screening, biodistribution, pharmacokinetics research, and pharmacodynamics evaluation for pharmaceutical companies and research institutions both domestically and internationally. Additionally, Mitro provides a one-stop comprehensive solution for new drug development related to radiopharmaceuticals, including labeling method development, pharmaceutical research, non-clinical research, clinical research, and registration application.
Related News